Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-25 @ 8:07 PM
NCT ID:
NCT00129935
Group ID:
EG001
Title:
Arm B: ET-X
Description:
Epirubicin and docetaxel followed by capecitabine (ET-X):Epirubicin 90 mg/m2 and docetaxel 75 mg/ m2 (ET) every 21 days for 4 cycles, followed by capecitabine 1,250 mg/m2 bid for 14 days, followed by a 7-day rest for 4 cycles.
Docetaxel
Capecitabine
Epirubicin
Deaths Number Affected:
83
Deaths Number At Risk:
None
Serious Number Affected:
138
Serious Number At Risk:
715
Other Number Affected:
699
Other Number At Risk:
715
Study:
NCT00129935
Results Section:
NCT00129935
Adverse Events Module:
NCT00129935